12:00 AM
Apr 15, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Daiichi Sankyo, Kowa sales and marketing update

Daiichi and Kowa said the companies terminated their Japanese commercialization partnership for Kowa's cholesterol drug Livalo pitavastatin and Daiichi's hypertension drug Olmetec olmesartan...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >